Article
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
Molecular cancer research : MCR - 1 Aug 2014
Malik Rohit, Patel Lalit, Prensner John R, Shi Yang, Iyer Matthew K, Subramaniyan Shruthi, Carley Alexander, Niknafs Yashar S, Sahu Anirban, Han Sumin, Ma Teng, Liu Meilan, Asangani Irfan A, Jing Xiaojun, Cao Xuhong, Dhanasekaran Saravana M, Robinson Dan R, Feng Felix Y, Chinnaiyan Arul M
Abstract excerpt
UNLABELLED: Long noncoding RNAs (lncRNA) have recently been associated with the development and progression of a variety of human cancers. However, to date, the interplay between known oncogenic or tumor-suppressive events and lncRNAs has not been well described. Here, the novel lncRNA, prostate cancer-associated transcript 29 (PCAT29), is characterized along with its relationship to the androgen receptor. PCAT29...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.